Our study has unveiled the detailed landscape of both immune and nonimmune cells in the microenvironment of CRC and highlighted the potential value of identifying and developing therapeutic strategies targeting FAP+ fibroblasts, SPP1+ macrophages, or the molecules involved in their crosstalk to overcome immune suppression and increase the response of tumors to immunotherapies. The gene discussed is SPP1; the disease is colorectal carcinoma.